AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03009695 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Sham stimulation will be performed by an H-sham-coil. The H-sham-coil is designed to mimic the auditory artifacts and the scalp sensation evoked by the real coil, without stimulating the brain itself. As in the other groups, in each patient the rMT will be determined before each repetitive dTMS session. The sham stimulation will be performed either at high frequency (50% of subjects) or at low-frequency (50% of subjects), according to the previously described methodologies. All obese people in this group will be submitted at the sight of food preferred (cue).
Study NCT05446246 — intervention group
Intervention type: PROCEDURE
Intervention: Bariatric surgery
Description: Sleeve gastrectomy
Study NCT01690949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PUR118
Description: inhaled PUR118, BID
Study NCT00591383 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: indibulin
Description: indibulin, dose escalation, 200 mg - 600 mg. Taken twice every day.
Study NCT00591383 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib
Description: erlotinib taken at 150 mg every morning with food.
Study NCT02648815 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous catheter drainage
Description: Depending on the operator experience, tandem trocar technique or Seldinger technique can be used. If the Seldinger technique is used, then the catheter tract should be sequentially dilated over a guidewire. Access routes that avoid crossing the bowel and other intervening organs, or major mesenteric, peripancreatic, or retroperitoneal blood vessels are selected to minimize the risk of bacterial contamination and hemorrhage. Successful percutaneous treatment of necrotic collections of the pancreas depends on several important factors. Catheters often need to remain in place for several weeks and sometimes months; hence, close follow-up is required.
Study NCT02648815 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Abdominal paracentesis evacuation
Description: Evacuation of peritoneal ascitic fluid using percutaneous catheters
Study NCT02968394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: omalizumab
Study NCT03688113 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tinnitus application
Description: Use of tinnitus application
Study NCT03688113 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Tinnitus application
Description: Use of tinnitus application
Study NCT02734914 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SF-URS with automatic control of RPP
Description: A new F-URS monitoring and control of RPP using intelligent pressure control device
Study NCT02734914 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: conventional F-URS
Description: Ureteroscopy will be conducted using the ureteral access sheath from Cook Medical to treat renal calculi.
Study NCT01098578 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Floseal
Description: Received 1 syringe of Floseal as treatment for posterior epistaxis.
Study NCT04180878 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Participants received a interactive physical activity monitoring system that allowed study personnel to monitor their activity level.
Study NCT04180878 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention 2
Description: Participants received an interactive physical activity monitoring system, an electronic scale to report weekly body weight, weekly hour long conference calls with structured interactive educational lessons led by Health Educator, dietary recalls were completed at three different time points during their participation, and study personnel monitored physical activity levels weekly.
Study NCT04626531 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Web-Based Education
Description: Participants in the intervention group had unlimited access to the Web site, free of charge. The Web site was designed to run on personal computers and smartphones.
Study NCT04626531 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: The control group didn't apply any interference during the study. Participants in the control group continued their routine follow-up.
Study NCT03372915 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Exposure
Description: Exposure therapy conducted according to standard clinical care practices
Study NCT03372915 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure + Inhibitory Learning
Description: Exposure therapy conducted according to practice recommendations based derived from research on inhibitory learning theories of fear extinction
Study NCT04002427 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Infusion
Description: 30 µg \[14C\]AZD7594 containing 6.7 kBq (180 nCi) carbon-14 (14C) as a 1 hour infusion.
Study NCT04002427 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inhaled dose
Description: A single inhalation on one occasion.
Study NCT01864096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: One month run-in of 850mg metformin once daily, followed by 850mg twice daily of metformin for 35 months. Total time is 36 months.
Study NCT01864096 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One month run-in of placebo tablet once daily, followed by twice daily for 35 months. Total time is 36 months.
Study NCT04464902 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: brace1
Description: The brace1 can provide resistance when patients want to extend their knee.
Study NCT04464902 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: brace2
Description: The brace1 can't provide resistance when patients want to extend their knee.
Study NCT04464902 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No Intervention
Description: Control Group don't have any brace.
Study NCT02205359 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: aCRT ON
Description: CRT device with AdaptivCRT enabled (AdaptivBiV and LV)
Study NCT01914718 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-EPOCH-R
Description: rituximab 375mg/m2 IV day 0, etoposide 50mg/m2/d CIV days 1-4, doxorubicin 10mg/m2/d CIV days 1-4, vincristine 0.4mg/m2/d CIV days 1-4, cyclophosphamide 750mg/m2 IV day 5, prednisone 50mg PO days 1-5 twice per day
Study NCT02205359 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: aCRT OFF
Description: CRT device with AdaptivCRT disabled
Study NCT00657904 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: once daily
Study NCT01607723 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: NAVA ventilatory mode
Description: The two ventilatory modes will be studied during 24h in intubated patients in random order.
Study NCT01607723 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: PAV+ ventilatory mode
Description: The two ventilatory modes will be studied during 24h in intubated patients in random order.
Study NCT04396912 — intervention group
Intervention type: PROCEDURE
Intervention: Total thyroidectomy
Description: Patients with thyroid diseases either benign (e.g. multinodular goitre) or malign (e.g. thyroid carcinoma) will be prepared for total thyroidectomy procedure and will be enrolled.
Study NCT02776267 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Angiolite stent
Description: Following index PCI, patients will be followed via scheduled clinic and/or phone contact at 1-, 3-, 6-, 12- and 24-month. Patient will be randomized to undergo a scheduled repeat coronary angiogram and OCT evaluation at either at 3- or 6-month post index PCI.
Study NCT04493749 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ECG measurement
Description: Simultaneous recording of a single-lead ECG signal with the Withings Move ECG and ECG signal for the reference 12-lead ECG
Study NCT02832921 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive training by virtual reality
Study NCT02832921 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: cognitive training by virtual reality
Study NCT02832921 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: watching a scientific TV documentary
Study NCT02832921 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: treadmill
Description: VR cognitive training will be augmented by walking on a treadmill, since it is well established that dual tasking-i.e. performing the VR-based cognitive effort together with a motor task, even as simple as walking on a treadmill-places greater demand on cognitive resources than a single task.
Study NCT02832921 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: treadmill
Description: VR cognitive training will be augmented by walking on a treadmill, since it is well established that dual tasking-i.e. performing the VR-based cognitive effort together with a motor task, even as simple as walking on a treadmill-places greater demand on cognitive resources than a single task.
Study NCT02193724 — intervention group
Intervention type: OTHER
Intervention: Skin Biopsy
Description: A very small skin sample will be taken from the participant's arm. This will only be performed while the patient is under sedation for clinical purposes (e.g. exam under anesthesia, MRI, or other procedure requiring sedation).
Study NCT02193724 — intervention group
Intervention type: OTHER
Intervention: Blood Draw
Description: About 1 teaspoon of blood will be drawn from the participant's arm or from a central line catheter if present. Blood collection will be done at the same time the participant has blood drawn for routine clinical care.
Study NCT03049215 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lumen Apposing Metal Stent (LAMS)
Description: The AXIOS Stent and Electrocautery-Enhanced Delivery System is an endoscopic device designed to enable the ultrasound trained interventional endoscopist to deliver a transenteric stent between the gastrointestinal tract and a pancreatic pseudocyst.
Study NCT03049215 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LAMS plus double pigtail stent
Description: The AXIOS Stent and Electrocautery-Enhanced Delivery System is an endoscopic device designed to enable the ultrasound trained interventional endoscopist to deliver a transenteric stent between the gastrointestinal tract and a pancreatic pseudocyst. The double pigtail stent is a routinely used plastic biliary stent.
Study NCT01796444 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sentinel Lymph Node Biopsy
Description: Sentinel lymph nodes are identified with the combining use of intraoperative gamma detector and/or blue dye.
Study NCT01796444 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sentinel Lymph Node Biopsy
Description: Sentinel lymph nodes are identified with the combining use of intraoperative gamma detector and/or blue dye.
Study NCT01796444 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intraoperative Pathological Examination
Description: touch imprint cytology and/or frozen section and/or OSNA
Study NCT01796444 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraoperative Pathological Examination
Description: touch imprint cytology and/or frozen section and/or OSNA
Study NCT01796444 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Axillary Lymph Node Dissection
Description: Axillary lymph node dissection involving removal of at least level I and II nodes.
Study NCT01796444 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pathological Evaluation
Description: H\&E and IHC
Study NCT01796444 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pathological Evaluation
Description: H\&E and IHC
Study NCT01796444 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adjuvant Systemic Therapy
Description: Adjuvant systemic therapy was determined by the treating physician according to the recently NCCN.
Study NCT01796444 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adjuvant Systemic Therapy
Description: Adjuvant systemic therapy was determined by the treating physician according to the recently NCCN.
Study NCT01796444 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy
Description: Whole-breast opposing tangential-field radiation therapy.
Study NCT01796444 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Whole-breast opposing tangential-field radiation therapy.
Study NCT01922414 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laser
Description: Patients will undergo laser lithotripsy durin PNL
Study NCT01922414 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasonic
Description: Patients will undergo ultrasonic lithotripsy during PNL
Study NCT02278237 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VME Group
Description: Received inhaler education through VME (virtual education module)
Study NCT03368560 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sudarshan Kriya Yoga
Description: Sudarshan Kriya Yoga (SKY): A 12-week training course conducted by certified instructors from the Art of Living Foundation. SKY training will take place in group-format (group sizes of 8-15 participants) in an appropriately sized and accessible community hall in London, Ontario.SKY training involves attending a week-long (5 days) course that teaches the basic principles of SKY over 2.5-3 hour daily sessions. This will be followed by once weekly follow up sessions (90 min/wk) for 3 weeks and then bimonthly sessions (every 2 weeks) for the next 8 weeks. In addition, participants will be asked to practice SKY at home daily (25 min/day) throughout the duration of the study period and log practice frequency and any other noteworthy observations in a log sheet that will be provided to them . Nutritional snacks will be provided during the 5 day SKY training course.
Study NCT01491165 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: stem cell transplantation through interventional procedures
Description: one time interventional procedures
Study NCT01391871 — intervention group
Intervention type: DEVICE
Intervention: OCT
Description: Optical coherence tomography
Study NCT01391871 — intervention group
Intervention type: DEVICE
Intervention: Transthoracic echocardiography CFR measurement
Description: CFR will be assessed using transthoracic echocardiography with adenosine infusion.
Study NCT00469027 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: eNOS transfected EPCs will be delivered via a PA line
Description: incremental dosing over 3 days
Study NCT00666471 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MICE
Description: MICE
Study NCT00666471 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SPA ligation
Description: SPA ligation
Study NCT01164969 — intervention group
Intervention type: DRUG
Intervention: Antibiotics to which H. pylori can not develope resistance
Description: Amoxicillin, metronidazole and tetracyclin as primary drugs to treat H. pylori infection in duration of 10 days.
Study NCT02473874 — intervention group
Intervention type: DEVICE
Intervention: Skin Spect dermoscope
Description: Skin imaging
Study NCT02473874 — intervention group
Intervention type: DEVICE
Intervention: Spatially modulated quantitative
Description: Skin imaging
Study NCT03189953 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 68Ga-NODAGA-exendin 4 PET/CT
Description: 68Ga-NODAGA-exendin 4 PET/CT
Study NCT02842671 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Assigned Ambassador
Description: If assigned to the intervention group, participants will be contacted by the assigned medical student ambassador at least 1 day prior to the procedure. A brief discussion will take place to review the child's history and survey results. The family will be met by the Ambassador at the hospital and stay with the family until the patient is in the post anesthesia recovery unit. The ambassador is expected to make accommodations for the child as determined by the accommodations survey results. The family will be required to allow the Ambassador to stay through check-in and the procedure.
Study NCT04652843 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Rectosignoidoscopy
Description: Rectosignoidoscopy for colonic biospsies collection
Study NCT00906789 — intervention group
Intervention type: BEHAVIORAL
Intervention: Software
Description: This is an observer performance study. Radiologists will interpret chest radiographs without and then with the Riverain software, both SoftView (TM) OnGuard (TM) CADe Software with be tested
Study NCT02011503 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Multi-layer compression therapy
Description: Application of multi-layer compression therapy.
Study NCT02011503 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multi-layer compression therapy
Description: Application of multi-layer compression therapy.
Study NCT02011503 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Application of dHACM
Description: Application of dHACM to ulcer.
Study NCT00095303 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Strategic Family Therapy (BSFT)
Description: BSFT is a family therapy approach that consists of 12 to 16 sessions (each 1 to 1.5 hours long) over a 4-month period during the Main Study, and up to 8 booster sessions. Interventions are delivered to adolescents and relevant family members in non-restrictive community settings (e.g., clinics, homes, school).
Study NCT00095303 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual
Description: TAU varies depending on site, however each will offer services that include at least 1 therapy session (individual or group therapy) per week during the Main Study, as well as participation in ancillary services (e.g., case management, self help groups, etc.) over a four month period.
Study NCT01364467 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Children aged 7-11 years old will receive placebo 200 mg three times a day (TID), while children older than 12 will receive Placebo 400 mg TID.
Study NCT01364467 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Guaifenesin
Description: Children aged 7-11 years old will receive guaifenesin 200 mg TID, while children older than 12 will receive guaifenesin 400 mg TID.
Study NCT03784430 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Immediate dental implant placement
Description: Tooth will be extracted and a dental implant will be positioned at the same time.
Study NCT03784430 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immediate dental implant placement with CTG
Description: Tooth will be extracted and a dental implant will be positioned at the same time with a connective tissue graft.
Study NCT04652843 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Coloscopy
Description: Coloscopy for colonic biospsies collection
Study NCT04356508 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Single dose at 0.3mg/kg
Study NCT00582179 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Pressure Dressing
Description: If hematoma still draining at 5 days post surgery, patients who randomize to Group A will have a standard pressure dressing applied and checked every 24-48 hours for continued draining. If still draining at 10 days post surgery, patient is at end point of study and must return to OR for Irrigation and Debridement of the wound. If infection occurs, patient is at end point of study and must return to OR for I\&D.
Study NCT00582179 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VAC
Description: If hematoma still draining at 5 days post surgery, patients who randomize to Group B will have a VAC negative pressure device applied and checked every 24-48 hours for continued draining. If still draining at 10 days post surgery, patient is at end point of study and must return to OR for Irrigation and Debridement of the wound. If infection occurs, patient is at end point of study and must return to OR for I\&D.
Study NCT02783937 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Filgrastim
Description: Each case will have two intervention phases done blindly at random with a wash-out period of 6 months:~Phase A:~Filgrastim vial (30 million IU/ml) SC injection twice daily for five consecutive days.~Phase B:~Injection of saline SC injection twice daily for five consecutive days.
Study NCT01094054 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adjustable gastric banding
Description: Placement of adjustable gastric band - laparoscopically
Study NCT01094054 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dietary and lifestyle modification
Description: Dietary and lifestyle modification~Subjects will meet with a dietitian and a psychologist on a weekly basis and consume a diet matched to that of the banding arm
Study NCT01385930 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle counseling
Description: Lifestyle counseling
Study NCT03155503 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SUVN-911
Description: Oral Tablet
Study NCT03155503 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Oral Tablet
Study NCT02783937 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Injection of saline SC injection twice daily for five consecutive days